No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs6831585 |
chr4:15776181-15776182 |
Strong transcription Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs145146576 |
chr4:15776195-15776196 |
Strong transcription Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs9637595 |
chr4:15776199-15776200 |
Strong transcription Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs576401028 |
chr4:15776295-15776296 |
Bivalent Enhancer Strong transcription Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs539010071 |
chr4:15776373-15776374 |
Bivalent Enhancer Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs142099513 |
chr4:15776434-15776435 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs572668517 |
chr4:15776456-15776457 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs566507218 |
chr4:15776459-15776460 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs575050600 |
chr4:15776478-15776479 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs115726192 |
chr4:15776514-15776515 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs561102645 |
chr4:15776523-15776524 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs574196641 |
chr4:15776529-15776530 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs543158295 |
chr4:15776567-15776568 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs563033234 |
chr4:15776581-15776582 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs532044552 |
chr4:15776586-15776587 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs552129127 |
chr4:15776601-15776602 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs559403095 |
chr4:15776631-15776632 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs542077545 |
chr4:15776653-15776654 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs548409546 |
chr4:15776656-15776657 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs568310467 |
chr4:15776683-15776684 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs537236031 |
chr4:15776776-15776777 |
Strong transcription Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs550334283 |
chr4:15776835-15776836 |
Strong transcription Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs66998564 |
chr4:15776861-15776862 |
Strong transcription Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
24 |
rs538682620 |
chr4:15776867-15776868 |
Strong transcription Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs558874100 |
chr4:15776974-15776975 |
Strong transcription Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs572657516 |
chr4:15777047-15777048 |
Strong transcription Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs185186959 |
chr4:15777060-15777061 |
Strong transcription Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs372174655 |
chr4:15777062-15777063 |
Strong transcription Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs574731376 |
chr4:15777067-15777068 |
Strong transcription Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs190074039 |
chr4:15777098-15777099 |
Strong transcription Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs146375561 |
chr4:15777165-15777166 |
Strong transcription Weak transcription Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs576838202 |
chr4:15777265-15777266 |
Strong transcription Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs114823994 |
chr4:15777292-15777293 |
Strong transcription Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs552164221 |
chr4:15777328-15777329 |
Strong transcription Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs181148901 |
chr4:15777387-15777388 |
Strong transcription Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs139304802 |
chr4:15777413-15777414 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs548544910 |
chr4:15777502-15777503 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs561950150 |
chr4:15777546-15777547 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs185500917 |
chr4:15777553-15777554 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs13105588 |
chr4:15777582-15777583 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
41 |
rs570064826 |
chr4:15777589-15777590 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs28429904 |
chr4:15777596-15777597 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs552289757 |
chr4:15777602-15777603 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs371751229 |
chr4:15777607-15777608 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs144224511 |
chr4:15777655-15777656 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs187961807 |
chr4:15777674-15777675 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs201508372 |
chr4:15777784-15777785 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs554876821 |
chr4:15777860-15777861 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs6449180 |
chr4:15777881-15777882 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs148707834 |
chr4:15777893-15777894 |
Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|